PEDIATRICS Vol. 22 No. 2 August 1958, pp. 309-318
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shields, G. S.
Right arrow Articles by Watson, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shields, G. S.
Right arrow Articles by Watson, R. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

STUDIES IN SICKLE CELL DISEASE

I. Quantitative Aspects of Sickling in the Newborn Period

George S. Shields M.D.1, Herbert C. Lichtman M.D.1, Jacqueline Messite M.D.1, and R. Janet Watson M.D.1

1 Departments of Medicine and Pediatrics, State University of New York, Downstate Medical Center, and the Kings County Hospital, Brooklyn, New York

In newborn infants with sickle cell trait, the percentage of erythrocytes capable of being sickled in vitro gradually rose during the first 4 months of life. A concomitant fall in the percentage of Hgb F was demonstrated. The percentage of cells which could be induced to assume the sickled shape was found not to be correlated with the percentage of Hgb S, but instead was correlated with the reciprocal of the concentration of Hgb F.

The specific reaction rate of alkali resistant hemoglobin in the infants less than 3 months of age was found to differ from that found in adults and in infants more than 3 months of age.

Submitted on February 28, 1958
Accepted on March 25, 1958


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 JAMAHome page
J. F. Jackson, J. L. Odom, and W. N. Bell
Amelioration of Sickle Cell Disease by Persistent Fetal Hemoglobin
JAMA, September 23, 1961; 177(12): 867 - 869.
[Abstract] [PDF]